<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04437576</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00020328</org_study_id>
    <nct_id>NCT04437576</nct_id>
  </id_info>
  <brief_title>Pregnancy and Latent Labor Biomarkers and Symptoms to Predict Cervical Dilation at Hospital Admission.</brief_title>
  <official_title>Pregnancy and Latent Labor Biomarkers and Symptoms to Predict Cervical Dilation at Hospital Admission.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bloomlife Technologies</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical Research Foundation, Oregon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>OHSU School of Nursing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed pilot investigation is a prospective, observational study of 300 healthy&#xD;
      nulliparous women with spontaneous term labor onset. The specific aims of this study are to:&#xD;
&#xD;
      Aim #1: Characterize IL-8 (pro-inflammatory biomarker), basal body temperature, maternal&#xD;
      heart rate, and electrical activity of the uterus prior to spontaneous onset of labor through&#xD;
      the onset of active labor among nulliparous women. IL-8 will be quantified weekly, daily&#xD;
      basal body temperature, as well as continuous maternal heart rate and electrical activity of&#xD;
      the uterus throughout the transition from late pregnancy into active labor.&#xD;
&#xD;
      Aim #2: Characterize latent labor symptoms among nulliparous women in spontaneous labor.&#xD;
      Using Likert scale, childbirth-specific, symptom-specific PROMIS measures,45 and open-ended&#xD;
      questions will be quantified and characterize latent labor symptoms (e.g., intensity,&#xD;
      frequency) and identify relevant themes.&#xD;
&#xD;
      Aim #3: Characterize trajectories of labor biomarkers and latent labor symptoms across latent&#xD;
      labor duration. A modified growth mixture modeling approach to quantify subgroup phenotypes&#xD;
      among nulliparous women in spontaneous latent labor will be employed.&#xD;
&#xD;
      Hypothesis 3.1. There will be significant congruence between higher biomarkers (e.g., higher&#xD;
      IL-8, more uterine electrical activity) and symptoms that are more intense and frequent.&#xD;
&#xD;
      Hypothesis 3.2. At least two classes of laboring women with distinct trajectories of change&#xD;
      in biomarkers and symptoms can be identified and will be associated with cervical dilation at&#xD;
      hospital admission.&#xD;
&#xD;
      Exploratory Aim: Characterize biomarkers among nulliparous women with spontaneous labor onset&#xD;
      vs. nulliparous women requiring labor induction for post-term gestation. Weekly IL-8, daily&#xD;
      basal body temperature, as well as continuous maternal heart rate and electrical activity of&#xD;
      the uterus throughout the transition from late pregnancy into active labor between those&#xD;
      whose labor begins spontaneously and those whose labors are induced for post-term gestation&#xD;
      will be quantified.&#xD;
&#xD;
      Exploratory Hypothesis. There will be different biomarker patterns between women with&#xD;
      spontaneous labor onset vs. those without.&#xD;
&#xD;
      The Standard descriptive and inferential statistics as well as growth mixture modeling for&#xD;
      quantitative aims will be used. The investigators will use thematic development for&#xD;
      qualitative aims.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 13, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Interleukin-8 (IL-8) expression during latent phase of labor to delivery</measure>
    <time_frame>week 37, week 38, week 39, week 40, week 41, week 42, upon admission for labor to OHSU</time_frame>
    <description>Measure of IL-8 in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in Basal body temperature during latent phase of labor to delivery</measure>
    <time_frame>Daily from 37 weeks gestation until admission to hospital for labor</time_frame>
    <description>Measure body temperature first thing every morning until admission to hospital for birth.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Maternal heart rate during latent phase of labor to delivery</measure>
    <time_frame>Continuously from 37 weeks gestation until admission to hospital for labor</time_frame>
    <description>Wearable sensor worn to record heart rate continually.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in electrical activity of the uterus during latent phase of labor to delivery</measure>
    <time_frame>Continuously from 37 weeks gestation until admission to hospital for labor</time_frame>
    <description>Wearable sensor that records signals detected on the surface of the abdomen (e.g. signals generated by the uterus) and movements.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characterize latent labor symptoms among nulliparous women in spontaneous labor</measure>
    <time_frame>week 37, week 38, week 39, week 40, week 41, week 42, upon admission for labor to OHSU</time_frame>
    <description>Quantify and characterize latent labor symptoms and identify relevant themes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize trajectories of latent labor biomarkers across latent labor duration</measure>
    <time_frame>week 37, week 38, week 39, week 40, week 41, week 42, upon admission for labor to OHSU</time_frame>
    <description>Quantify subgroup phenotypes among nulliparous women in spontaneous latent labor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize trajectories of latent labor symptoms across latent labor duration</measure>
    <time_frame>week 37, week 38, week 39, week 40, week 41, week 42, upon admission for labor to OHSU</time_frame>
    <description>Quantify subgroup phenotypes among nulliparous women in spontaneous latent labor using growth mixture modeling viewing longitudinal change.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in Basal body temperature comparison in spontaneous labor vs induction</measure>
    <time_frame>week 37, week 38, week 39, week 40, week 41, week 42, upon admission for labor to OHSU</time_frame>
    <description>Quantified weekly basal body temperature comparison throughout the transition from late pregnancy into active labor between those whose labor begins spontaneously and those whose labors are induced for post-term gestation.</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in continuous maternal heart rate comparison in spontaneous labor vs induction</measure>
    <time_frame>week 37, week 38, week 39, week 40, week 41, week 42, upon admission for labor to OHSU</time_frame>
    <description>Quantified maternal heart rate comparison throughout the transition from late pregnancy into active labor between those whose labor begins spontaneously and those whose labors are induced for post-term gestation.</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in IL-8 comparison in spontaneous labor vs induction</measure>
    <time_frame>week 37, week 38, week 39, week 40, week 41, week 42, upon admission for labor to OHSU</time_frame>
    <description>Quantified weekly IL-8 comparison throughout the transition from late pregnancy into active labor between those whose labor begins spontaneously and those whose labors are induced for post-term gestation.</description>
  </other_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Labor Onset Biomarkers</condition>
  <condition>Labor Onset</condition>
  <condition>Cervical Dilation</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This is a study of reproductive age women 20-39 years of age being performed at Oregon&#xD;
        Health &amp; Science University (OHSU) in Portland, OR. It will include subjects who present&#xD;
        for prenatal care in our outpatient Center for Women's Health Clinics and OHSU Labor and&#xD;
        Delivery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Nulliparous&#xD;
&#xD;
          2. Maternal age of at least 20 years of age.&#xD;
&#xD;
          3. Maternal age of no greater than 39 years of age.&#xD;
&#xD;
          4. Viable, term pregnancy: â‰¥ 37 weeks gestation at time of signing study consent.&#xD;
&#xD;
          5. Able to understand and provide an informed consent.&#xD;
&#xD;
          6. Able to understand English.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Multiple gestation (i.e., carrying &gt;1 fetus)&#xD;
&#xD;
          2. Managing complex comorbidities (e.g., preeclampsia)&#xD;
&#xD;
          3. Documented fetal congenital anomalies&#xD;
&#xD;
          4. Preterm labor and birth&#xD;
&#xD;
          5. Persistent breech fetal position at term&#xD;
&#xD;
          6. Fetal death prior to the onset of labor&#xD;
&#xD;
          7. Any indication for planned cesarean birth (e.g., placenta previa)&#xD;
&#xD;
          8. Induction of labor for medical indication (e.g., oligohydramnios)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Ellen Tilden, PhD, CNM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>OHSU</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 2, 2020</study_first_submitted>
  <study_first_submitted_qc>June 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2020</study_first_posted>
  <last_update_submitted>June 16, 2020</last_update_submitted>
  <last_update_submitted_qc>June 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Ellen Tilden</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

